Trilateral wins the ‘Best Use of R&D’ prize at the Invest in Ireland Awards 2023

Reading Time: 2 minutes


Trilateral Research |

Date: 17 February 2023

Trilateral Research was awarded the Best Use of R&D prize for our work in the healthcare-research sector during the Invest in Ireland Awards ceremony on 16 February 2023. 

This award recognises the positive impact of Trilateral’s work to support the improvement and protection of public health in sustainable innovation, particularly in the context of the EU-funded COVINFORM and iToBoS projects.

The Invest in Ireland Awards’ vision is to recognise and honour the contribution that the Foreign Direct Investment (FDI) sector makes to the Irish Economy and the fabric of Irish Life across Tech and MedTech, Pharma, Green Economy, Financial Services, Business Services, and Engineering. The FDI sector is a major part of the Irish economic success story, and the Invest in Ireland Awards aims to shine a light on the positive contribution that companies make to Ireland and the Irish economy. In attendance at the ceremony were the Minister for Enterprise, Trade and Employment, Simon Coveney TD and the Interim CEO of the IDA, Mary Buckley.

Trilateral Research is the technical and social-science partner in the COVINFORM project. The project was launched in the EU to help analyse COVID-19 responses on the levels of government, public health, community, and information and communications, with a focus on the impacts on vulnerable individuals and groups. Trilateral has led the development of a risk assessment model that combines quantitative and qualitative data in an easy-to-use dashboard for policymakers and researchers. By using Trilateral’s dashboard, users can understand COVID-19 vulnerability beyond health and demographics, and conduct their own modelling to better plan future evidence-based policies.

For the iToBoS project, Trilateral Research leads the research on the privacy, data protection, ethical, and societal issues. The project aims to develop AI-based solutions for improving dermatologists’ diagnostic accuracy of Melanoma. Trilateral is conducting a comprehensive privacy impact assessment of the iToBoS technologies to ensure the secure handling of patient data complying with existing regulations at both European and national levels. We also developed novel techniques for achieving algorithmic transparency and dealing with issues such as algorithmic bias and interpretability.

Trilateral Research has invested significant energies and resources to make a positive and tangible impact through our work in Ireland, and have been rewarded with a highly-skilled team who are passionate about their work and who bring the rigour of research to sustainable innovation. I could not be prouder of our achievements and of the team who have contributed to this milestone. We are deeply honoured by this important recognition, which provides an opportunity for our work to have an even greater impact”, said Kush Wadhwa, CEO of Trilateral Research. 

Trilateral Research is an Ethical AI company based in Waterford and London (UK) and provides Ethical AI software solutions, advisory services, and research services in Ireland, the UK, Europe and the United States. Its 130+ staff have expertise in Ethical AI, data protection, cybersecurity, and quantitative and qualitative research in multiple critically important sectors, including law enforcement, crisis and security, human rights, and environment.

Read more about Trilateral Research’s work here.

EU flag

The COVINFORM and iToBoS projects are co-funded by the European Union (Horizon 2020 Research and Innovation Programme, GA Nos 101016247 and 965221).

Related posts

Let's discuss your career